Prof. Dr. Dr. Christian Michael Grimm (Principal Investigator)
+49-89-2180-73811
External links:
Christian Grimm is a Professor of Molecular Pharmacology at the Walther-Straub-Institute of Pharmacology and Toxicology, Medical Faculty, Ludwig-Maximilians-University (LMU) Munich, Germany. Christian has been working in the field of ion channels, in particular TRP channels for almost 20 years, starting as a PhD Student at the Free University (FU) of Berlin, Germany, followed by postdoctoral research fellowships at Harvard University and Stanford University, USA (2004-2009). In 2009 Christian joined pharmaceutical industry (Pfizer Ltd., UK) as a principal scientist working on ion channels as targets to treat neuropathic pain. In 2011, Christian returned to Germany and to academia as a group leader in pharmacology at the Department of Chemistry and Pharmacy of the LMU Munich. Since then he has focused his research on endo-lysosomal ion channels, in particular TRPML channels and two-pore channels (TPCs), resulting in several high-profile publications in PNAS, EMBO J., Nature Commun., Nature Protoc., and Science. For his work he received several awards, the Ernst-Reuter Award of the Free University Berlin (2005), the NCL Foundation Award (2016), and the Care for Rare Award of the LMU Munich Childrens' Hospital (2017).
Dr. Anna Scotto Rosato, PhD (Postdoc)
+49-89-2180-73822
DFG-funded
Dr. Dawid Jaslan, PhD (Postdoc)
+49-89-2180-73835
DFG-funded
Einar K. Krogsaeter (PhD Student), Start 08/17
+49-89-2180-73809
(funded by Mucolipidosis IV Foundation, USA,
NCL Foundation and Care-for-Rare Foundation)
Barbara Spix (PhD Student), Start 09/18
+49-89-2180-73836
DFG-funded
(GRK2338 Targets in Toxicology - Deciphering Therapeutic Targets in Lung Toxicology)
Julia Böck (PhD Student), Start 11/18
+49-89-2180-73809 or -73805
LMU-funded
Carla Abrahamian (PhD Student), Start 04/19
(LMU- and DFG-funded)
+49-89-2180-73822 or -73805
Rachel Tang (PhD Student), Start 07/19
LMU-funded
+49-89-2180-73823 or -73805
Alina Nakhabina (MD Student), Start 08/19
Funded by GRK2338 Targets in Toxicology - Deciphering Therapeutic
